Perspective Therapeutics (CATX) FCF Payout Ratio (2015)
Perspective Therapeutics recorded quarterly FCF Payout Ratio of 0.0 in Q2 2015.
Perspective Therapeutics' FCF Payout Ratio history runs 1 years deep, the most recent figure standing at 0.0 for Q2 2015.
- In Q2 2015, FCF Payout Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2017 stood at 0.0 (changed N/A YoY), while the FY2021 annual figure was 0.0, changed 0.49% from the prior year.
- FCF Payout Ratio came in at 0.0 for Q2 2015 at Perspective Therapeutics.
- In the past five years, FCF Payout Ratio ranged from a high of 0.0 in Q2 2015 to a low of 0.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.40 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.08 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.25 |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 0.00 |